Literature DB >> 21045962

Identical Mutation in SH3BP2 Gene Causes Clinical Phenotypes with Different Severity in Mother and Daughter - Case Report.

L Preda1, O Dinca, A Bucur, C Dragomir, E Severin.   

Abstract

Cherubism is a particular form of fibrous dysplasia of the jaws. Familial occurrence was reported in most cases. The condition is a rare hereditary disorder with autosomal dominant inheritance, with complete penetrance in males and incomplete penetrance in females and variable expressivity. It is known to be caused by mutations in the gene encoding SH3-domain binding protein 2, SH3BP2 gene. Major diagnostic criteria are cherubic facial appearance, painless hard enlargement of the jaws, and frequently associated dental abnormalities. The aim of the study was to analyze clinical and genetic features of cherubism in a family with 3 daughters in which the youngest one was affected. Clinical and radiographic examinations, hematological and biochemical evaluations and biopsy were performed. Molecular genetic analysis consisted of PCR amplification and direct sequencing of selected exons of the SH3BP2 gene. Cherubism was suspected based on clinical and radiographic examinations of the 9-year-old daughter. She presented asymmetrical enlargement of the mandible, speech and swallowing problems and dental abnormalities on the lower jaw. There was no history of similar clinical findings in any of the daughters or the parents of the affected girl. Abnormal results were obtained by genetic analysis. A c.1244G>A mutation was identified in exon 9 of the SH3BP2 gene in the asymptomatic mother and her affected daughter. The identified mutation in the SH3BP2 gene is probably disease-causing. The asymptomatic mother transmitted the gene mutation to her affected daughter. Our results confirm the reduced penetrance and variable expression of the gene mutation.

Entities:  

Year:  2010        PMID: 21045962      PMCID: PMC2941844          DOI: 10.1159/000314268

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  14 in total

1.  Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism.

Authors:  Y Ueki; V Tiziani; C Santanna; N Fukai; C Maulik; J Garfinkle; C Ninomiya; C doAmaral; H Peters; M Habal; L Rhee-Morris; J B Doss; S Kreiborg; B R Olsen; E Reichenberger
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

2.  [Clinical and molecular genetic observations on families with cherubism over three generations].

Authors:  M Petschler; M Stiller; B Hoffmeister; R Witkowski; C Opitz; J S Bill; H Peters
Journal:  Mund Kiefer Gesichtschir       Date:  2003-01-11

3.  Temporal bone involvement in cherubism: case report.

Authors:  Luciana Cardoso Fonseca; João Batista de Freitas; Pedro Hernane Maciel; Marcelo Gusmão Paraiso Cavalcanti
Journal:  Braz Dent J       Date:  2004-08-16

4.  Cherubism - new hypotheses on pathogenesis and therapeutic consequences.

Authors:  Peter Hyckel; Alexander Berndt; Peter Schleier; Joachim H Clement; Volkmar Beensen; Hartmut Peters; Hartwig Kosmehl
Journal:  J Craniomaxillofac Surg       Date:  2005-01-12       Impact factor: 2.078

5.  A new mutation in the SH3BP2 gene showing reduced penetrance in a family affected with cherubism.

Authors:  Jan de Lange; Merel C van Maarle; Hans P van den Akker; Egbert J W Redeker
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-09-26

6.  Cherubism: clinicoradiographic features, treatment, and long-term follow-up of 8 cases.

Authors:  Edgard Carvalho Silva; Guilherme Costa Carvalho Silva; Tainah Couto Vieira
Journal:  J Oral Maxillofac Surg       Date:  2007-03       Impact factor: 1.895

7.  Novel mutations in the SH3BP2 gene associated with sporadic central giant cell lesions and cherubism.

Authors:  V M Carvalho; P F Perdigão; F R Amaral; P E A de Souza; L De Marco; R S Gomez
Journal:  Oral Dis       Date:  2008-11-11       Impact factor: 3.511

8.  [Genetic aspects of cherubism].

Authors:  M Brix; H Peters; E Ranfaing; B Ricbourg
Journal:  Rev Stomatol Chir Maxillofac       Date:  2006-04

9.  Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation.

Authors:  Steven A Lietman; Natasha Kalinchinko; Xichao Deng; Ronald Kohanski; Michael A Levine
Journal:  Hum Mutat       Date:  2006-07       Impact factor: 4.878

10.  Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism.

Authors:  Bryan Lo; M Faiyaz-Ul-Haque; S Kennedy; R Aviv; L-C Tsui; Ahmad S Teebi
Journal:  Am J Med Genet A       Date:  2003-08-15       Impact factor: 2.802

View more
  5 in total

1.  Genetic study of an Indian family with cherubism.

Authors:  Ankur Singh; Khushbu Singh; Ruchi Goel; Ying Hu; Ernst Reichenberger; Seema Kapoor
Journal:  Indian J Pediatr       Date:  2013-09-05       Impact factor: 1.967

Review 2.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

3.  Clinicopathologic and Molecular Characteristics of Familial Cherubism with Associated Odontogenic Tumorous Proliferations.

Authors:  Prokopios P Argyris; Rajaram Gopalakrishnan; Ying Hu; Ernst J Reichenberger; Ioannis G Koutlas
Journal:  Head Neck Pathol       Date:  2017-07-18

Review 4.  Cherubism: best clinical practice.

Authors:  Maria E Papadaki; Steven A Lietman; Michael A Levine; Bjorn R Olsen; Leonard B Kaban; Ernst J Reichenberger
Journal:  Orphanet J Rare Dis       Date:  2012-05-24       Impact factor: 4.123

5.  Cherubism as a systemic skeletal disease: evidence from an aggressive case.

Authors:  Anne Morice; Aline Joly; Manon Ricquebourg; Gérard Maruani; Emmanuel Durand; Louise Galmiche; Jeanne Amiel; Yoann Vial; Hélène Cavé; Kahina Belhous; Marie Piketty; Martine Cohen-Solal; Ariane Berdal; Corinne Collet; Arnaud Picard; Amelie E Coudert; Natacha Kadlub
Journal:  BMC Musculoskelet Disord       Date:  2020-08-21       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.